![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 21, 18146-18152, May 25, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Human Biological Chemistry and Genetics,
University of Texas Medical Branch, Galveston, Texas 77555
The activation domains of many transcription
factors appear to exist naturally in an unfolded or only partially
folded state. This seems to be the case for AF1/tau1, the major
transactivation domain of the human glucocorticoid receptor. We show
here that in buffers containing the natural osmolyte trimethylamine
N-oxide (TMAO), recombinant AF1 folds into more a compact
structure, as evidenced by altered fluorescence emission, circular
dichroism spectra, and ultracentrifugal analysis. This conformational
transition is cooperative, a characteristic of proteins folding to
natural structures. The structure resulting from incubation in TMAO
causes the peptide to resist proteolysis by trypsin, chymotrypsin,
endoproteinase Arg-C and endoproteinase Gluc-C. Ultracentrifugation
studies indicate that AF1/tau1 exists as a monomer in aqueous solution
and that the presence of TMAO does not lead to oligomerization or
aggregation. It has been suggested that recombinant AF1 binds both the
ubiquitous coactivator CBP and the TATA box-binding protein, TBP.
Interactions with both of these are greatly enhanced in the presence of
TMAO. Co-immunoadsorption experiments indicate that in TMAO each of these and the coactivator SRC-1 are found complexed with AF1. These
data indicate that TMAO induces a conformation in AF1/tau1 that is
important for its interaction with certain co-regulatory proteins.
The Conformation of the Glucocorticoid Receptor AF1/tau1 Domain
Induced by Osmolyte Binds Co-regulatory Proteins*
*
This work was supported by NCI Grant 5RO1 CA 41407 and
NIDDKD Grant 1R01 DK58829-01 from the National Institutes of Health (to
E. B. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Human Biological Chemistry and Genetics, University of Texas Medical Branch, 301 University Blvd., 605 Basic Science Bldg., Galveston, TX
77555-0645. Tel.: 409-772-2271; Fax: 409-772-5159; E-mail: bthompso@utmb.edu.
This article has been cited by other articles:
![]() |
W. Chen, T. Dang, R. D. Blind, Z. Wang, C. N. Cavasotto, A. B. Hittelman, I. Rogatsky, S. K. Logan, and M. J. Garabedian Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression Mol. Endocrinol., August 1, 2008; 22(8): 1754 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Weigel and N. L. Moore Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions Mol. Endocrinol., October 1, 2007; 21(10): 2311 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tung, H. Abdel-Hafiz, T. Shen, D. M. E. Harvell, L. K. Nitao, J. K. Richer, C. A. Sartorius, G. S. Takimoto, and K. B. Horwitz Progesterone Receptors (PR)-B and -A Regulate Transcription by Different Mechanisms: AF-3 Exerts Regulatory Control over Coactivator Binding to PR-B Mol. Endocrinol., November 1, 2006; 20(11): 2656 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Copik, M. S. Webb, A. L. Miller, Y. Wang, R. Kumar, and E. B. Thompson Activation Function 1 of Glucocorticoid Receptor Binds TATA-Binding Protein in Vitro and in Vivo Mol. Endocrinol., June 1, 2006; 20(6): 1218 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wardell, S. C. Kwok, L. Sherman, R. S. Hodges, and D. P. Edwards Regulation of the Amino-Terminal Transcription Activation Domain of Progesterone Receptor by a Cofactor-Induced Protein Folding Mechanism Mol. Cell. Biol., October 15, 2005; 25(20): 8792 - 8808. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brodie and I. J McEwan Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding J. Mol. Endocrinol., June 1, 2005; 34(3): 603 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Miller, M. S. Webb, A. J. Copik, Y. Wang, B. H. Johnson, R. Kumar, and E. B. Thompson p38 Mitogen-Activated Protein Kinase (MAPK) Is a Key Mediator in Glucocorticoid-Induced Apoptosis of Lymphoid Cells: Correlation between p38 MAPK Activation and Site-Specific Phosphorylation of the Human Glucocorticoid Receptor at Serine 211 Mol. Endocrinol., June 1, 2005; 19(6): 1569 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshikawa, K. Yamamoto, N. Shimizu, S. Yamada, C. Morimoto, and H. Tanaka The Distinct Agonistic Properties of the Phenylpyrazolosteroid Cortivazol Reveal Interdomain Communication within the Glucocorticoid Receptor Mol. Endocrinol., May 1, 2005; 19(5): 1110 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh, I. Haque, and F. Ahmad Counteracting Osmolyte Trimethylamine N-Oxide Destabilizes Proteins at pH below Its pKa: MEASUREMENTS OF THERMODYNAMIC PARAMETERS OF PROTEINS IN THE PRESENCE AND ABSENCE OF TRIMETHYLAMINE N-OXIDE J. Biol. Chem., March 25, 2005; 280(12): 11035 - 11042. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cho, B. L. Kagan, J. A. Blackford Jr., D. Szapary, and S. S. Simons Jr. Glucocorticoid Receptor Ligand Binding Domain Is Sufficient for the Modulation of Glucocorticoid Induction Properties by Homologous Receptors, Coactivator Transcription Intermediary Factor 2, and Ubc9 Mol. Endocrinol., February 1, 2005; 19(2): 290 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, D. E. Volk, J. Li, J. C. Lee, D. G. Gorenstein, and E. B. Thompson TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain PNAS, November 23, 2004; 101(47): 16425 - 16430. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, J. A. Blackford Jr., L.-N. Song, Y. Huang, S. Cho, and S. S. Simons Jr. Equilibrium Interactions of Corepressors and Coactivators with Agonist and Antagonist Complexes of Glucocorticoid Receptors Mol. Endocrinol., June 1, 2004; 18(6): 1376 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takano, S. Adachi, M. Okuno, Y. Muto, T. Yoshioka, R. Matsushima-Nishiwaki, H. Tsurumi, K. Ito, S. L. Friedman, H. Moriwaki, et al. The RING Finger Protein, RNF8, Interacts with Retinoid X Receptor {alpha} and Enhances Its Transcription-stimulating Activity J. Biol. Chem., April 30, 2004; 279(18): 18926 - 18934. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar and E. B. Thompson Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bommer, A. Benecke, H. Gronemeyer, and C. Rochette-Egly TIF2 Mediates the Synergy between RARalpha 1 Activation Functions AF-1 and AF-2 J. Biol. Chem., September 27, 2002; 277(40): 37961 - 37966. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Hazra, Y. W. Kow, Z. Hatahet, B. Imhoff, I. Boldogh, S. K. Mokkapati, S. Mitra, and T. Izumi Identification and Characterization of a Novel Human DNA Glycosylase for Repair of Cytosine-derived Lesions J. Biol. Chem., August 16, 2002; 277(34): 30417 - 30420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reid, S. M. Kelly, K. Watt, N. C. Price, and I. J. McEwan Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation. INFLUENCE OF STRUCTURE-STABILIZING SOLUTES AND PROTEIN-PROTEIN INTERACTIONS J. Biol. Chem., May 24, 2002; 277(22): 20079 - 20086. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tung, T. Shen, M. G. Abel, R. L. Powell, G. S. Takimoto, C. A. Sartorius, and K. B. Horwitz Mapping the Unique Activation Function 3 in the Progesterone B-receptor Upstream Segment. TWO LXXLL MOTIFS AND A TRYPTOPHAN RESIDUE ARE REQUIRED FOR ACTIVITY J. Biol. Chem., October 19, 2001; 276(43): 39843 - 39851. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Song and D. T. Chuang Natural Osmolyte Trimethylamine N-Oxide Corrects Assembly Defects of Mutant Branched-chain alpha -Ketoacid Decarboxylase in Maple Syrup Urine Disease J. Biol. Chem., October 19, 2001; 276(43): 40241 - 40246. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |